24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BioProtect
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:32
Fiverr appoints Yossi Levin as new CTO
15:22
Israeli defense industry targets new threats with cutting-edge drone defense systems
15:04
From importing computer parts to a $160 million exit: KSP’s founders cash in on retail empire
14:04
Trump administration targets Temu and Shein with crackdown on duty-free imports
More stories
Buzz
Most popular
Daily
Weekly
1
Intel slashes employee bonuses amid financial struggles
2
Intel pulls the plug on AI chip designed to rival Nvidia
3
Deel secures $300M secondary transaction at over $12B valuation, hits $800M revenue run rate
4
Unicorn AppsFlyer lays off 100 employees in strategic restructuring
5
Bigabid raises $25 million Series A to boost gaming adtech growth
More news
BioProtect
3 stories about BioProtect
Is it time to reconsider PSA tests for Prostate Cancer?
01.09.22
|
Itay Barnea
“The treating physician should determine what is best for the patient based on his unique age, family history, health, lifestyle, race, ethnic background, and other factors,” writes Itay Barnea, CEO of BioProtect
Which Israeli cancer treatment company raised $57 million and who is making money off double chins?
22.09.20
|
CTech
CTech Daily Roundup: Medtronic invests $4.5 million as part of BioProtect $25 million series D
Medtronic invests $4.5 million as part of BioProtect $25 million series D
22.09.20
|
Meir Orbach
Proceeds of the round will finance the ongoing multicenter FDA clinical trial of BioProtect's lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy